[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354931-105":59,"doc-detail-354931-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","maternal-embryonic-leucine-zipper-kinase-melk-in-cancer-biological-functions-therapeutic-potential-and-controversies","Maternal Embryonic Leucine Zipper Kinase (MELK) in Cancer - Biological Functions, Therapeutic Potential, and Controversies","","The review consolidates current knowledge on Maternal Embryonic Leucine Zipper Kinase (MELK), a serine/threonine kinase implicated in cell-cycle progression, proliferation, apoptosis, migration, and stem-like tumor features. MELK overexpression is described across multiple malignancies, often associating with aggressive phenotypes, poor survival, and treatment resistance. Therapeutic strategies are summarized, including small-molecule inhibitors and MELK-targeting RNAi, with OTSSP167 showing clinical signals. Limitations and controversies are addressed, concluding MELK may function as a conditional oncogenic vulnerability rather than a universal driver.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/maternal-embryonic-leucine-zipper-kinase-melk-in-cancer-biological-functions-therapeutic-potential-and-controversies/354931/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/maternal-embryonic-leucine-zipper-kinase-melk-in-cancer-biological-functions-therapeutic-potential-and-controversies/354931.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biological roles does MELK regulate in cancer cells?","Question",{"text":112,"@type":113},"MELK regulates cell-cycle progression, proliferation, apoptosis, migration, and tumor stemness, and is linked to survival and invasive behavior.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is MELK connected to prognosis and treatment outcomes?",{"text":117,"@type":113},"Elevated MELK levels are commonly associated with aggressive disease, poor survival, resistance to therapy, and stem-like tumor characteristics.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is MELK considered controversial as a universal cancer driver?",{"text":121,"@type":113},"Some studies using genetic knockout report limited effects on proliferation, while discrepancies may stem from off-target effects, context differences across cancer types, and study conditions.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354931,1790298814,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Review  \nMaternal Embryonic Leucine Zipper Kinase (MELK) in Cancer: Biological Functions, Therapeutic Potential, and Controversies Alaeddin M. Alzeer  and Saad Al-Lahham *  \nAcademic Editor: Claudio Luparello  \nReceived: 5 November 2025  \nRevised: 10 January 2026  \nAccepted: 15 January 2026  \nPublished: 21 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nDepartment of Biomedical Sciences and Basic Clinical Skills, Faculty of Medicine and Allied Medical Sciences, An-Najah National University, Nablus P.O. Box 7, Palestine; [s12170254@stu.najah.edu](s12170254@stu.najah.edu)  \n* Correspondence: [saedallahham@gmail.com](saedallahham@gmail.com); Fax: +970-92345982  \nSimple Summary  \nMELK is a serine/threonine kinase that regulates cell cycle progression, proliferation, apoptosis, migration, and stemness. MELK is overexpressed in many solid and hematologic malignancies. Furthermore, high MELK levels correlate with aggressive disease, poor survival, treatment resistance, and cancer stem-like features. Several small-molecule inhibitors and RNAi-targeting MELK have suppressed the development and progression of various cancers. OTSSP167 has shown promising results in phase I and II clinical trials. However, a study employing CRISPR/Cas9 knockout in breast cancer cell lines reported that loss of MELK did not impair proliferation. The review concludes that MELK is a robust prognostic biomarker of proliferation and aggressive behavior across multiple cancers but is not a universal driver of tumor growth. Discrepancies may arise from off-target effects of RNAi or inhibitors, context differences across cancer types, and differences in study settings. MELK is proposed as a conditional oncogenic vulnerability, especially in p53-deficient triple-negative breast cancer (TNBC) and glioma stem cells. Further research is needed to clarify the target selectivity of inhibitors, context-specific dependencies, and the optimal use of MELK-focused agents in combination therapies rather than as standalone treatments.  \nAbstract  \nThe Maternal Embryonic Leucine Zipper Kinase (MELK) gene is a member of the Snf1/AMPK serine/threonine kinase family. MELK has recently attracted considerable interest in cancer biology due to its aberrant overexpression in various malignancies, including glioma, breast, lung, colorectal, gastric, and hematological cancers. It has been shown that higher MELK levels are often correlated with unfavorable prognosis, aggressive tumor manifestations, resistance to treatment, and stem-like tumor morphologies. In this review we aim to summarize the current understanding of MELK biology, including its functions in cell cycle regulation, apoptosis, oncogenic signaling pathways, and tumor stemness. We also discuss the therapeutic potential, limitations, and controversy of MELK inhibitors, and implications in cancer diagnosis and treatment. MELK may not be a universal driver oncogene; nonetheless, it is consistently linked to aggressive disease, underscoring its potential as a prognostic biomarker and a candidate for therapeutic co-targeting in combination treatments.  \nKeywords: MELK; CRISPR/Cas9; RNAi; OTSSP167  \n1. Introduction  \nMELK gene is a member of the Snf1/AMPK serine/threonine kinase family. MELKcDNA was initially cloned in 1997 (Figure 1) and was initially recognized through its expression among several early embryonic cellular stages [1,2] . This initial finding implicated MELK in essential developmental processes, including embryogenesis and cell cycle regulation [3] . Additionally, it serves as a multifunctional kinase, participating in various biological and cellular processes. These functions include the stringent regulation of cell cycle progression [4], enhancement of cell proliferation [3], enhancement of mitosis [5], modulation of apoptosis [3,6], prom","cbCairhVh2V7NQ1D","https://ap.wps.com/l/cbCairhVh2V7NQ1D","pdf",1901058,"English","# Introduction\n## Structure of MELK","[{\"question\":\"What biological roles does MELK regulate in cancer cells?\",\"answer\":\"MELK regulates cell-cycle progression, proliferation, apoptosis, migration, and tumor stemness, and is linked to survival and invasive behavior.\"},{\"question\":\"How is MELK connected to prognosis and treatment outcomes?\",\"answer\":\"Elevated MELK levels are commonly associated with aggressive disease, poor survival, resistance to therapy, and stem-like tumor characteristics.\"},{\"question\":\"Why is MELK considered controversial as a universal cancer driver?\",\"answer\":\"Some studies using genetic knockout report limited effects on proliferation, while discrepancies may stem from off-target effects, context differences across cancer types, and study conditions.\"}]","Maternal Embryonic Leucine Zipper Kinase (MELK) in Cancer - Biological Functions, Therapeutic Potential, and Controversies | PDF",1790114911,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60a996a755104574b762c6dda13908be.webp",983,1390,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f7b278be40263d7a705f8cebcfe00a6.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76f2c33fc6a921b83e0ccdcd754bb182.webp",981,1387,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23542432fee5c5ecfc8b9df419e16bc0.webp",980,1385]